Orchid Pharma Ltd.

Financial

	Orchid Pharma	Guj. Themis Biosyn	Unichem Lab
Operational Metrics
Financials
5 yr Average ROE	-4.13 %	41.95 %	-0.79 %
5yr average Equity Multiplier	1.73	1.37	1.32
5yr Average Asset Turnover Ratio	0.45	0.89	0.47
5yr Avg Net Profit Margin	-7.02 %	34.6 %	-1.68 %
Price to Book	3.16	15.72	1.55
P/E	40.18	87.53	29.0
5yr Avg Cash Conversion Cycle	49.11 Days	-31.8 Days	88.84 Days
Inventory Days	112.59 Days	23.52 Days	151.32 Days
Days Receivable	91.49 Days	48.29 Days	122.86 Days
Days Payable	201.52 Days	135.34 Days	205.05 Days
5yr Average Interest Coverage Ratio	-0.51	187.52	2.41
5yr Avg ROCE	0.51 %	54.74 %	1.04 %
5yr Avg Operating Profit Margin	10.69 %	45.69 %	5.43 %
5 yr average Debt to Equity	0.49	0.05	0.11
5yr CAGR Net Profit	n/a	20.11 %	32.0 %
5yr Average Return on Assets	-1.77 %	30.29 %	-0.65 %
Shareholdings
Promoter Holding	69.84 %	70.86 %	70.22 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-20.12 %	-4.13 %	19.29 %
Change in Mutual Fund Holding (3 Yrs)	16.13 %	1.14 %	1.31 %

Business

	Orchid Pharma	Guj. Themis Biosyn	Unichem Lab
Product Wise Break-Up	Product Wise Break-Up Oral Formulations 76.42 Sterile 23.58 0 Bulk Drugs and chemicals 0 Formulations 0	Product Wise Break-Up Oral Formulations 0 Bulk Drugs and chemicals 0 Sterile 0 Pharmaceutical 100.0 Formulations 0	Product Wise Break-Up Oral Formulations 0 Bulk Chemicals 7.7 Sterile 0 0 Formulations 92.3
Location Wise Break-Up	Location Wise Break-Up India 18.32 USA 0 Others 81.68	-	Location Wise Break-Up India 1.97 USA 64.2 Others 33.83
Asset Break-Up - Geography Wise	Asset Break-Up - Geography Wise Others 100	-	-